SNOWMASS, COLO. – When it comes to prescribing rituximab in patients with rheumatoid arthritis, maybe it’s time to think like a European.
In res... More »
SNOWMASS, COLO. – A novel approach to repairing anterior cruciate ligament injuries – and perhaps thereby avoiding a downstream tidal wave of knee... More »
SNOWMASS, COLO. – A full decade after a large multicenter study identified non-Hodgkin’s lymphoma as the major cancer risk associated with SLE, it... More »
SNOWMASS, COLO. – The risk of irreversible hydroxychloroquine toxic retinopathy is much greater than previously appreciated, Dr. James T. Rosenbaum ... More »
After a 5-year monopoly on the sale of colchicine put the gout medication out of reach for many patients, a federal judge in January denied an injunct... More »
Systematic lupus erythematosus is not a risk factor for poor outcomes after total hip or knee arthroplasty, according to Dr. Ummara H. Shah and her as... More »
Measuring proteinuria 12 months into a clinical trial is the best way to predict long-term renal outcomes in lupus nephritis patients, according to re... More »
Two years of either triple therapy or treatment with tumor necrosis factor plus methotrexate failed to eliminate joint inflammation on MRI in a subcoh... More »
Asian and Hispanic patients with systemic lupus erythematosus have lower all-cause mortality rates than white, black, and Native American patients, ac... More »
Patients with poor-prognosis early rheumatoid arthritis who have been on a regimen of abatacept for at least 1 year and have low disease activity scor... More »